Global Pharmaceutical Testing 麻豆原创 Growth (Status and Outlook) 2024-2030

Publication ID:

LPI07247933

Publication Date:

July 24, 2024

Pages:

101

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Pharmaceutical Testing market size is projected to grow from US$ 6689 million in 2024 to US$ 9331 million in 2030; it is expected to grow at a CAGR of 5.7% from 2024 to 2030.
LPI (LP Information)' newest research report, the 鈥淧harmaceutical Testing Industry Forecast鈥� looks at past sales and reviews total world Pharmaceutical Testing sales in 2022, providing a comprehensive analysis by region and market sector of projected Pharmaceutical Testing sales for 2023 through 2029. With Pharmaceutical Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pharmaceutical Testing industry.
This Insight Report provides a comprehensive analysis of the global Pharmaceutical Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Pharmaceutical Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Pharmaceutical Testing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pharmaceutical Testing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pharmaceutical Testing.
China Pharmaceutical Testing core manufacturers are WuXi AppTec銆丆TI銆乄eipu銆丳ONY Medicine銆丼GS銆乄uXi Biologics and etc, the top five manufacturers account for about 14% of the Chinese share. Wuxi AppTec has the largest market, with a presence in more than 30 countries worldwide.. In terms of product type, Drug Packaging Material Testing is the largest segment with a share of about 27%. And in terms of application, Finished Drugs and Environment is the largest downstream segment with a share of 38%.
This report presents a comprehensive overview, market shares, and growth opportunities of Pharmaceutical Testing market by product type, application, key players and key regions and countries.
Segmentation by Type:
Raw Material Testing
Microbiological Testing
Drug Packaging Material Testing
Macromolecule Drug Biological Analysis and Testing
GMP Public System and Equipment Validation Testing
Pharmacovigilance
Other
Segmentation by Application:
CRO
CMO and CDMO
Finished Drugs and Environment
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Segmentation by Type:
Raw Material Testing
Microbiological Testing
Drug Packaging Material Testing
Macromolecule Drug Biological Analysis and Testing
GMP Public System and Equipment Validation Testing
Pharmacovigilance
Other
Segmentation by Application:
CRO
CMO and CDMO
Finished Drugs and Environment
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
WuXi AppTec
CTI
Weipu
PONY Medicine
SGS
WuXi Biologics
Eurofins
Standard Group
ICAS
APTBIO
Saifu Lab
GBTc
Kerbio
Assure
NIFDC

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Pharmaceutical Testing 麻豆原创 Size 2019-2030
2.1.2 Pharmaceutical Testing 麻豆原创 Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Pharmaceutical Testing by Country/Region, 2019, 2023 & 2030
2.2 Pharmaceutical Testing Segment by Type
2.2.1 Raw Material Testing
2.2.2 Microbiological Testing
2.2.3 Drug Packaging Material Testing
2.2.4 Macromolecule Drug Biological Analysis and Testing
2.2.5 GMP Public System and Equipment Validation Testing
2.2.6 Pharmacovigilance
2.2.7 Other
2.3 Pharmaceutical Testing 麻豆原创 Size by Type
2.3.1 Pharmaceutical Testing 麻豆原创 Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Pharmaceutical Testing 麻豆原创 Size 麻豆原创 Share by Type (2019-2024)
2.4 Pharmaceutical Testing Segment by Application
2.4.1 CRO
2.4.2 CMO and CDMO
2.4.3 Finished Drugs and Environment
2.5 Pharmaceutical Testing 麻豆原创 Size by Application
2.5.1 Pharmaceutical Testing 麻豆原创 Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Pharmaceutical Testing 麻豆原创 Size 麻豆原创 Share by Application (2019-2024)
3 Pharmaceutical Testing 麻豆原创 Size by Player
3.1 Pharmaceutical Testing 麻豆原创 Size 麻豆原创 Share by Player
3.1.1 Global Pharmaceutical Testing Revenue by Player (2019-2024)
3.1.2 Global Pharmaceutical Testing Revenue 麻豆原创 Share by Player (2019-2024)
3.2 Global Pharmaceutical Testing Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Pharmaceutical Testing by Region
4.1 Pharmaceutical Testing 麻豆原创 Size by Region (2019-2024)
4.2 Global Pharmaceutical Testing Annual Revenue by Country/Region (2019-2024)
4.3 Americas Pharmaceutical Testing 麻豆原创 Size Growth (2019-2024)
4.4 APAC Pharmaceutical Testing 麻豆原创 Size Growth (2019-2024)
4.5 Europe Pharmaceutical Testing 麻豆原创 Size Growth (2019-2024)
4.6 Middle East & Africa Pharmaceutical Testing 麻豆原创 Size Growth (2019-2024)
5 Americas
5.1 Americas Pharmaceutical Testing 麻豆原创 Size by Country (2019-2024)
5.2 Americas Pharmaceutical Testing 麻豆原创 Size by Type (2019-2024)
5.3 Americas Pharmaceutical Testing 麻豆原创 Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pharmaceutical Testing 麻豆原创 Size by Region (2019-2024)
6.2 APAC Pharmaceutical Testing 麻豆原创 Size by Type (2019-2024)
6.3 APAC Pharmaceutical Testing 麻豆原创 Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Pharmaceutical Testing 麻豆原创 Size by Country (2019-2024)
7.2 Europe Pharmaceutical Testing 麻豆原创 Size by Type (2019-2024)
7.3 Europe Pharmaceutical Testing 麻豆原创 Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Pharmaceutical Testing by Region (2019-2024)
8.2 Middle East & Africa Pharmaceutical Testing 麻豆原创 Size by Type (2019-2024)
8.3 Middle East & Africa Pharmaceutical Testing 麻豆原创 Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global Pharmaceutical Testing 麻豆原创 Forecast
10.1 Global Pharmaceutical Testing Forecast by Region (2025-2030)
10.1.1 Global Pharmaceutical Testing Forecast by Region (2025-2030)
10.1.2 Americas Pharmaceutical Testing Forecast
10.1.3 APAC Pharmaceutical Testing Forecast
10.1.4 Europe Pharmaceutical Testing Forecast
10.1.5 Middle East & Africa Pharmaceutical Testing Forecast
10.2 Americas Pharmaceutical Testing Forecast by Country (2025-2030)
10.2.1 United States 麻豆原创 Pharmaceutical Testing Forecast
10.2.2 Canada 麻豆原创 Pharmaceutical Testing Forecast
10.2.3 Mexico 麻豆原创 Pharmaceutical Testing Forecast
10.2.4 Brazil 麻豆原创 Pharmaceutical Testing Forecast
10.3 APAC Pharmaceutical Testing Forecast by Region (2025-2030)
10.3.1 China Pharmaceutical Testing 麻豆原创 Forecast
10.3.2 Japan 麻豆原创 Pharmaceutical Testing Forecast
10.3.3 Korea 麻豆原创 Pharmaceutical Testing Forecast
10.3.4 Southeast Asia 麻豆原创 Pharmaceutical Testing Forecast
10.3.5 India 麻豆原创 Pharmaceutical Testing Forecast
10.3.6 Australia 麻豆原创 Pharmaceutical Testing Forecast
10.4 Europe Pharmaceutical Testing Forecast by Country (2025-2030)
10.4.1 Germany 麻豆原创 Pharmaceutical Testing Forecast
10.4.2 France 麻豆原创 Pharmaceutical Testing Forecast
10.4.3 UK 麻豆原创 Pharmaceutical Testing Forecast
10.4.4 Italy 麻豆原创 Pharmaceutical Testing Forecast
10.4.5 Russia 麻豆原创 Pharmaceutical Testing Forecast
10.5 Middle East & Africa Pharmaceutical Testing Forecast by Region (2025-2030)
10.5.1 Egypt 麻豆原创 Pharmaceutical Testing Forecast
10.5.2 South Africa 麻豆原创 Pharmaceutical Testing Forecast
10.5.3 Israel 麻豆原创 Pharmaceutical Testing Forecast
10.5.4 Turkey 麻豆原创 Pharmaceutical Testing Forecast
10.6 Global Pharmaceutical Testing Forecast by Type (2025-2030)
10.7 Global Pharmaceutical Testing Forecast by Application (2025-2030)
10.7.1 GCC Countries 麻豆原创 Pharmaceutical Testing Forecast
11 Key Players Analysis
11.1 WuXi AppTec
11.1.1 WuXi AppTec Company Information
11.1.2 WuXi AppTec Pharmaceutical Testing Product Offered
11.1.3 WuXi AppTec Pharmaceutical Testing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.1.4 WuXi AppTec Main Business Overview
11.1.5 WuXi AppTec Latest Developments
11.2 CTI
11.2.1 CTI Company Information
11.2.2 CTI Pharmaceutical Testing Product Offered
11.2.3 CTI Pharmaceutical Testing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.2.4 CTI Main Business Overview
11.2.5 CTI Latest Developments
11.3 Weipu
11.3.1 Weipu Company Information
11.3.2 Weipu Pharmaceutical Testing Product Offered
11.3.3 Weipu Pharmaceutical Testing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.3.4 Weipu Main Business Overview
11.3.5 Weipu Latest Developments
11.4 PONY Medicine
11.4.1 PONY Medicine Company Information
11.4.2 PONY Medicine Pharmaceutical Testing Product Offered
11.4.3 PONY Medicine Pharmaceutical Testing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.4.4 PONY Medicine Main Business Overview
11.4.5 PONY Medicine Latest Developments
11.5 SGS
11.5.1 SGS Company Information
11.5.2 SGS Pharmaceutical Testing Product Offered
11.5.3 SGS Pharmaceutical Testing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.5.4 SGS Main Business Overview
11.5.5 SGS Latest Developments
11.6 WuXi Biologics
11.6.1 WuXi Biologics Company Information
11.6.2 WuXi Biologics Pharmaceutical Testing Product Offered
11.6.3 WuXi Biologics Pharmaceutical Testing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.6.4 WuXi Biologics Main Business Overview
11.6.5 WuXi Biologics Latest Developments
11.7 Eurofins
11.7.1 Eurofins Company Information
11.7.2 Eurofins Pharmaceutical Testing Product Offered
11.7.3 Eurofins Pharmaceutical Testing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.7.4 Eurofins Main Business Overview
11.7.5 Eurofins Latest Developments
11.8 Standard Group
11.8.1 Standard Group Company Information
11.8.2 Standard Group Pharmaceutical Testing Product Offered
11.8.3 Standard Group Pharmaceutical Testing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.8.4 Standard Group Main Business Overview
11.8.5 Standard Group Latest Developments
11.9 ICAS
11.9.1 ICAS Company Information
11.9.2 ICAS Pharmaceutical Testing Product Offered
11.9.3 ICAS Pharmaceutical Testing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.9.4 ICAS Main Business Overview
11.9.5 ICAS Latest Developments
11.10 APTBIO
11.10.1 APTBIO Company Information
11.10.2 APTBIO Pharmaceutical Testing Product Offered
11.10.3 APTBIO Pharmaceutical Testing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.10.4 APTBIO Main Business Overview
11.10.5 APTBIO Latest Developments
11.11 Saifu Lab
11.11.1 Saifu Lab Company Information
11.11.2 Saifu Lab Pharmaceutical Testing Product Offered
11.11.3 Saifu Lab Pharmaceutical Testing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.11.4 Saifu Lab Main Business Overview
11.11.5 Saifu Lab Latest Developments
11.12 GBTc
11.12.1 GBTc Company Information
11.12.2 GBTc Pharmaceutical Testing Product Offered
11.12.3 GBTc Pharmaceutical Testing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.12.4 GBTc Main Business Overview
11.12.5 GBTc Latest Developments
11.13 Kerbio
11.13.1 Kerbio Company Information
11.13.2 Kerbio Pharmaceutical Testing Product Offered
11.13.3 Kerbio Pharmaceutical Testing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.13.4 Kerbio Main Business Overview
11.13.5 Kerbio Latest Developments
11.14 Assure
11.14.1 Assure Company Information
11.14.2 Assure Pharmaceutical Testing Product Offered
11.14.3 Assure Pharmaceutical Testing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.14.4 Assure Main Business Overview
11.14.5 Assure Latest Developments
11.15 NIFDC
11.15.1 NIFDC Company Information
11.15.2 NIFDC Pharmaceutical Testing Product Offered
11.15.3 NIFDC Pharmaceutical Testing Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.15.4 NIFDC Main Business Overview
11.15.5 NIFDC Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.